2025 Q3 -tulosraportti
74 päivää sitten42 min
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
35 975
Myynti
Määrä
26 841
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 494 | - | - | ||
| 9 068 | - | - | ||
| 10 932 | - | - | ||
| 2 200 | - | - | ||
| 1 620 | - | - |
Ylin
0,19VWAP
Alin
0,176VaihtoMäärä
0,8 4 623 422
VWAP
Ylin
0,19Alin
0,176VaihtoMäärä
0,8 4 623 422
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·2 päivää sitten · Muokattu@Micketro (Krosen) Did you take dilution into account when you claimed: https://forum.placera.se/inlagg/622912f1-c039-4ad6-8541-6b7c5937c07f AI says that the number you came up with would have placed you in the top 10 before the dilution took effect 😉 Also, one should remember that some of us are behind our broker's name: (from AI) : Anonymity: If you hold your shares through a "Kapitalförsäkring" (KF) or certain "Investeringssparkonto" (ISK) via a broker like Avanza or Nordnet, your name is often hidden behind the broker's name (e.g., "Avanza Pension").
·2 päivää sitten · MuokattuSeveral people on Placera have historically exposed themselves by name. Unnecessary. Of course, many stand behind a fund manager, but there are also many private individuals in the top 20 (ironically, no one from management or the board except Jeff)·2 päivää sitten · MuokattuThe 30-Day "Closed Period" Under Article 19(11) of MAR, insiders—technically called PDMRs (Persons Discharging Managerial Responsibilities)—are strictly prohibited from trading during: The 30 calendar days leading up to the publication of an interim (quarterly) report or a year-end report. The End Date: The ban only lifts once the report is made public. One day, someone on the board will probably use insider trading to boost the share price? It is at least very normal for something to be owned on the insider side. The question is probably just timing and how they will present this in a lawful manner.- ·3 päivää sitten · MuokattuI have a somewhat uneasy feeling that someone is coming in the days before Q4 and vacuuming up cheap shares 🫣 It's exactly what we need for a share price recovery, but this leaves a bit of a bad taste in the mouth to think that the share is so cheap when one doesn't get the joy of being able to buy so cheaply oneself. Many of us are stuck with what we bought previously. Then we'll see what is said at Q4, 24. February. Whether there will be light in this tunnel, or if it continues in a similar way. I believe that the management is working well, without having much reportable to give, before there is something reportable to give. At least it's a management that doesn't hype the stock with filler announcements in this company.·2 päivää sitten · MuokattuWhat is quite certain now is that the leader will not reveal anything new before Q4. He has said so himself. The exception is if an extraordinary general meeting is needed. Such as with what led to the now cancelled reverse split. Because there is also little time left until February 24.
·4.2.Why one likes this stock: Groundbreaking test: Early detection of pancreatic cancer can save lives and has great medical as well as commercial potential. Strong clinical results: The test has shown high accuracy in studies, which increases the chances for regulatory approval. Large market: The American and global market for cancer diagnostics is enormous, especially for early detection. First to market: Few competitors have equally advanced tests within the same segment.·3 päivää sitten@Micketro I rather thought they do medical imaging so they know where to direct the scalpel, direct the radiation therapy etc. Of course, it's used for diagnostics, but it's a tremendous waste of resources when there are biological molecules in the blood.- ·3.2. · MuokattuIt is Immunovia that is mentioned.. From a Gastro-linkedin: Pancreatic Cancer Detection Blood Test Shows 78% Sensitivity https://www.linkedin.com/posts/endosound_biomarker-asc-pancreaticcancer-activity-7422664635016994816-08eS With a doctor giving a comment: "Stuart Akerman, MD 4d Early detection saves lives, but only if patients can access the follow-up care they need. This new pancreatic cancer blood test is exciting. But every positive result needs an EUS for confirmation, localization, and staging. Hospital-based EUS is expensive and backlogged. We can't scale capacity fast enough to meet demand. That's why low-cost, high-efficiency EUS at ASCs isn't optional anymore. It's how we turn early detection into actual survival."·4.2.The doctor who is commenting obviously works for the company that makes cheaper EUS equipment. Even if what he says is correct in principle, it comes across a bit like someone who wants to defend their business idea to the very end 😅·4.2.Nice that :D. Worse with the IMMNOV share price currently. But one day..
- ·2.2. · MuokattuThe price is just completely tragic these days here. I understand that people are staying passive in trading. But, it will never get better if the volume remains so low. Since most who CHOOSE to trade now at these levels and ticks/spread only want the price to go down. If it had been such an overhyped stock, the opposite would have happened, perhaps even on low volume days. Then people would have bought small amounts here and there and enjoyed trading. Today in Immunovia, the spread is very wide, also often far from it simmering and there being enjoyment where people get in and out at pleasant levels from day to day. It's not possible to make money on 0.002 ticks. Maybe some shrewd ones manage it, but the usual small trader cannot profit from such differences. A Reverse split would at least have made the tick size significantly better. Just a small reasoning thought.·3.2. · MuokattuSo I think it's the sentiment that's somewhat bad, trading usually picks up when the sentiment picks up, normally. Of course, perhaps a tiny bit fewer in trading than before, when many months have passed without flat trading (pessimism). But, if there's momentum again, then it will probably get better in the long run. One can surely look at it as a love relationship that has cooled down and you have to find new love, that takes time.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
74 päivää sitten42 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·2 päivää sitten · Muokattu@Micketro (Krosen) Did you take dilution into account when you claimed: https://forum.placera.se/inlagg/622912f1-c039-4ad6-8541-6b7c5937c07f AI says that the number you came up with would have placed you in the top 10 before the dilution took effect 😉 Also, one should remember that some of us are behind our broker's name: (from AI) : Anonymity: If you hold your shares through a "Kapitalförsäkring" (KF) or certain "Investeringssparkonto" (ISK) via a broker like Avanza or Nordnet, your name is often hidden behind the broker's name (e.g., "Avanza Pension").·2 päivää sitten · MuokattuSeveral people on Placera have historically exposed themselves by name. Unnecessary. Of course, many stand behind a fund manager, but there are also many private individuals in the top 20 (ironically, no one from management or the board except Jeff)·2 päivää sitten · MuokattuThe 30-Day "Closed Period" Under Article 19(11) of MAR, insiders—technically called PDMRs (Persons Discharging Managerial Responsibilities)—are strictly prohibited from trading during: The 30 calendar days leading up to the publication of an interim (quarterly) report or a year-end report. The End Date: The ban only lifts once the report is made public. One day, someone on the board will probably use insider trading to boost the share price? It is at least very normal for something to be owned on the insider side. The question is probably just timing and how they will present this in a lawful manner.
- ·3 päivää sitten · MuokattuI have a somewhat uneasy feeling that someone is coming in the days before Q4 and vacuuming up cheap shares 🫣 It's exactly what we need for a share price recovery, but this leaves a bit of a bad taste in the mouth to think that the share is so cheap when one doesn't get the joy of being able to buy so cheaply oneself. Many of us are stuck with what we bought previously. Then we'll see what is said at Q4, 24. February. Whether there will be light in this tunnel, or if it continues in a similar way. I believe that the management is working well, without having much reportable to give, before there is something reportable to give. At least it's a management that doesn't hype the stock with filler announcements in this company.·2 päivää sitten · MuokattuWhat is quite certain now is that the leader will not reveal anything new before Q4. He has said so himself. The exception is if an extraordinary general meeting is needed. Such as with what led to the now cancelled reverse split. Because there is also little time left until February 24.
- ·4.2.Why one likes this stock: Groundbreaking test: Early detection of pancreatic cancer can save lives and has great medical as well as commercial potential. Strong clinical results: The test has shown high accuracy in studies, which increases the chances for regulatory approval. Large market: The American and global market for cancer diagnostics is enormous, especially for early detection. First to market: Few competitors have equally advanced tests within the same segment.·3 päivää sitten@Micketro I rather thought they do medical imaging so they know where to direct the scalpel, direct the radiation therapy etc. Of course, it's used for diagnostics, but it's a tremendous waste of resources when there are biological molecules in the blood.
- ·3.2. · MuokattuIt is Immunovia that is mentioned.. From a Gastro-linkedin: Pancreatic Cancer Detection Blood Test Shows 78% Sensitivity https://www.linkedin.com/posts/endosound_biomarker-asc-pancreaticcancer-activity-7422664635016994816-08eS With a doctor giving a comment: "Stuart Akerman, MD 4d Early detection saves lives, but only if patients can access the follow-up care they need. This new pancreatic cancer blood test is exciting. But every positive result needs an EUS for confirmation, localization, and staging. Hospital-based EUS is expensive and backlogged. We can't scale capacity fast enough to meet demand. That's why low-cost, high-efficiency EUS at ASCs isn't optional anymore. It's how we turn early detection into actual survival."·4.2.The doctor who is commenting obviously works for the company that makes cheaper EUS equipment. Even if what he says is correct in principle, it comes across a bit like someone who wants to defend their business idea to the very end 😅·4.2.Nice that :D. Worse with the IMMNOV share price currently. But one day..
- ·2.2. · MuokattuThe price is just completely tragic these days here. I understand that people are staying passive in trading. But, it will never get better if the volume remains so low. Since most who CHOOSE to trade now at these levels and ticks/spread only want the price to go down. If it had been such an overhyped stock, the opposite would have happened, perhaps even on low volume days. Then people would have bought small amounts here and there and enjoyed trading. Today in Immunovia, the spread is very wide, also often far from it simmering and there being enjoyment where people get in and out at pleasant levels from day to day. It's not possible to make money on 0.002 ticks. Maybe some shrewd ones manage it, but the usual small trader cannot profit from such differences. A Reverse split would at least have made the tick size significantly better. Just a small reasoning thought.·3.2. · MuokattuSo I think it's the sentiment that's somewhat bad, trading usually picks up when the sentiment picks up, normally. Of course, perhaps a tiny bit fewer in trading than before, when many months have passed without flat trading (pessimism). But, if there's momentum again, then it will probably get better in the long run. One can surely look at it as a love relationship that has cooled down and you have to find new love, that takes time.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
35 975
Myynti
Määrä
26 841
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 494 | - | - | ||
| 9 068 | - | - | ||
| 10 932 | - | - | ||
| 2 200 | - | - | ||
| 1 620 | - | - |
Ylin
0,19VWAP
Alin
0,176VaihtoMäärä
0,8 4 623 422
VWAP
Ylin
0,19Alin
0,176VaihtoMäärä
0,8 4 623 422
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
2025 Q3 -tulosraportti
74 päivää sitten42 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·2 päivää sitten · Muokattu@Micketro (Krosen) Did you take dilution into account when you claimed: https://forum.placera.se/inlagg/622912f1-c039-4ad6-8541-6b7c5937c07f AI says that the number you came up with would have placed you in the top 10 before the dilution took effect 😉 Also, one should remember that some of us are behind our broker's name: (from AI) : Anonymity: If you hold your shares through a "Kapitalförsäkring" (KF) or certain "Investeringssparkonto" (ISK) via a broker like Avanza or Nordnet, your name is often hidden behind the broker's name (e.g., "Avanza Pension").·2 päivää sitten · MuokattuSeveral people on Placera have historically exposed themselves by name. Unnecessary. Of course, many stand behind a fund manager, but there are also many private individuals in the top 20 (ironically, no one from management or the board except Jeff)·2 päivää sitten · MuokattuThe 30-Day "Closed Period" Under Article 19(11) of MAR, insiders—technically called PDMRs (Persons Discharging Managerial Responsibilities)—are strictly prohibited from trading during: The 30 calendar days leading up to the publication of an interim (quarterly) report or a year-end report. The End Date: The ban only lifts once the report is made public. One day, someone on the board will probably use insider trading to boost the share price? It is at least very normal for something to be owned on the insider side. The question is probably just timing and how they will present this in a lawful manner.
- ·3 päivää sitten · MuokattuI have a somewhat uneasy feeling that someone is coming in the days before Q4 and vacuuming up cheap shares 🫣 It's exactly what we need for a share price recovery, but this leaves a bit of a bad taste in the mouth to think that the share is so cheap when one doesn't get the joy of being able to buy so cheaply oneself. Many of us are stuck with what we bought previously. Then we'll see what is said at Q4, 24. February. Whether there will be light in this tunnel, or if it continues in a similar way. I believe that the management is working well, without having much reportable to give, before there is something reportable to give. At least it's a management that doesn't hype the stock with filler announcements in this company.·2 päivää sitten · MuokattuWhat is quite certain now is that the leader will not reveal anything new before Q4. He has said so himself. The exception is if an extraordinary general meeting is needed. Such as with what led to the now cancelled reverse split. Because there is also little time left until February 24.
- ·4.2.Why one likes this stock: Groundbreaking test: Early detection of pancreatic cancer can save lives and has great medical as well as commercial potential. Strong clinical results: The test has shown high accuracy in studies, which increases the chances for regulatory approval. Large market: The American and global market for cancer diagnostics is enormous, especially for early detection. First to market: Few competitors have equally advanced tests within the same segment.·3 päivää sitten@Micketro I rather thought they do medical imaging so they know where to direct the scalpel, direct the radiation therapy etc. Of course, it's used for diagnostics, but it's a tremendous waste of resources when there are biological molecules in the blood.
- ·3.2. · MuokattuIt is Immunovia that is mentioned.. From a Gastro-linkedin: Pancreatic Cancer Detection Blood Test Shows 78% Sensitivity https://www.linkedin.com/posts/endosound_biomarker-asc-pancreaticcancer-activity-7422664635016994816-08eS With a doctor giving a comment: "Stuart Akerman, MD 4d Early detection saves lives, but only if patients can access the follow-up care they need. This new pancreatic cancer blood test is exciting. But every positive result needs an EUS for confirmation, localization, and staging. Hospital-based EUS is expensive and backlogged. We can't scale capacity fast enough to meet demand. That's why low-cost, high-efficiency EUS at ASCs isn't optional anymore. It's how we turn early detection into actual survival."·4.2.The doctor who is commenting obviously works for the company that makes cheaper EUS equipment. Even if what he says is correct in principle, it comes across a bit like someone who wants to defend their business idea to the very end 😅·4.2.Nice that :D. Worse with the IMMNOV share price currently. But one day..
- ·2.2. · MuokattuThe price is just completely tragic these days here. I understand that people are staying passive in trading. But, it will never get better if the volume remains so low. Since most who CHOOSE to trade now at these levels and ticks/spread only want the price to go down. If it had been such an overhyped stock, the opposite would have happened, perhaps even on low volume days. Then people would have bought small amounts here and there and enjoyed trading. Today in Immunovia, the spread is very wide, also often far from it simmering and there being enjoyment where people get in and out at pleasant levels from day to day. It's not possible to make money on 0.002 ticks. Maybe some shrewd ones manage it, but the usual small trader cannot profit from such differences. A Reverse split would at least have made the tick size significantly better. Just a small reasoning thought.·3.2. · MuokattuSo I think it's the sentiment that's somewhat bad, trading usually picks up when the sentiment picks up, normally. Of course, perhaps a tiny bit fewer in trading than before, when many months have passed without flat trading (pessimism). But, if there's momentum again, then it will probably get better in the long run. One can surely look at it as a love relationship that has cooled down and you have to find new love, that takes time.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
35 975
Myynti
Määrä
26 841
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 494 | - | - | ||
| 9 068 | - | - | ||
| 10 932 | - | - | ||
| 2 200 | - | - | ||
| 1 620 | - | - |
Ylin
0,19VWAP
Alin
0,176VaihtoMäärä
0,8 4 623 422
VWAP
Ylin
0,19Alin
0,176VaihtoMäärä
0,8 4 623 422
Välittäjätilasto
Dataa ei löytynyt